Cheng Zhu resumes & CV records
Resumes
Cheng Julie Zhu
Cheng Zhu
Location:
United States
Cheng Lang Zhu, 5813630 Sanford Ave #2F, Flushing, NY 11355
Cheng Zhu Phones & Addresses
13630 Sanford Ave #2F, Flushing, NY 11355
13241 41St Ave, Flushing, NY 11355
10444 41St Ave, Corona, NY 11368 718-3960506
10444 41St Ave #1ST, Corona, NY 11368 718-3960506
Elmhurst, NY
4532 Gibson Ave, Saint Louis, MO 63110 314-6528995
4548 Gibson Ave, Saint Louis, MO 63110 314-6528995
4553 Gibson Ave, Saint Louis, MO 63110 314-5338437 314-6526880
6492 Clayton Ave, Saint Louis, MO 63139
Ballwin, MO
Washington, DC
Mentions for Cheng Lang Zhu
Publications & IP owners
Us Patents
Antidiabetic Tricyclic Compounds
US Patent:
2017008, Mar 23, 2017
Filed:
May 19, 2015
Appl. No.:
15/310488
Inventors:
Tesfaye BIFTU - Kenilworth NJ, US
Purakkattle BIJU - Boston MA, US
Timothy A. BLIZZARD - Princeton NJ, US
Zhengxia CHEN - Shanghai, CN
Matthew J. CLEMENTS - Old Bridge NJ, US
Mingxiang CUI - Shanghai, CN
Jessica L. FRIE - West Point PA, US
William K. HAGMANN - Westfield NJ, US
Bin HU - Shanghai, CN
Hubert JOSIEN - Kenilworth NJ, US
Anilkumar G. NAIR - Kenilworth NJ, US
Christopher W. PLUMMER - Kenilworth NJ, US
Cheng ZHU - Kenilworth NJ, US
- Rahway NJ, US
Purakkattle BIJU - Boston MA, US
Timothy A. BLIZZARD - Princeton NJ, US
Zhengxia CHEN - Shanghai, CN
Matthew J. CLEMENTS - Old Bridge NJ, US
Mingxiang CUI - Shanghai, CN
Jessica L. FRIE - West Point PA, US
William K. HAGMANN - Westfield NJ, US
Bin HU - Shanghai, CN
Hubert JOSIEN - Kenilworth NJ, US
Anilkumar G. NAIR - Kenilworth NJ, US
Christopher W. PLUMMER - Kenilworth NJ, US
Cheng ZHU - Kenilworth NJ, US
- Rahway NJ, US
International Classification:
C07D 221/16
A61K 31/438
C07D 405/12
C07D 401/12
A61K 31/444
C07C 61/39
A61K 31/192
A61K 31/4725
A61K 31/4709
A61K 31/538
C07D 413/12
A61K 31/55
C07D 215/14
A61K 31/47
C07D 401/04
A61K 45/06
A61K 31/438
C07D 405/12
C07D 401/12
A61K 31/444
C07C 61/39
A61K 31/192
A61K 31/4725
A61K 31/4709
A61K 31/538
C07D 413/12
A61K 31/55
C07D 215/14
A61K 31/47
C07D 401/04
A61K 45/06
Abstract:
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.
Possible Relatives
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.